Regeneron Pharmaceuticals
REGN
$899.70
Share price
-0.17%
Change (1 day)
9.75%
Change (1 year)
Categories
Regeneron Pharmaceuticals (REGN) - Total debt
Total debt on the balance sheet as of December 2023 : $2.70 B
According to Regeneron Pharmaceuticals's latest financial reports the company's total debt is $2.70 B. A company’s total debt is the sum of all current and non-current debts.
Regeneron Pharmaceuticals - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $2.70 B | 0.06% |
| 2022-12-31 | $2.70 B | 0.06% |
| 2021-12-31 | $2.69 B | 0.15% |
| 2020-12-31 | $2.69 B | 277.6% |
| 2019-12-31 | $0.71 B | 0.76% |
| 2018-12-31 | $0.70 B | 0.71% |
| 2017-12-31 | $0.70 B | 46.22% |
| 2016-12-31 | $0.48 B | 32.57% |
| 2015-12-31 | $0.36 B | -20.71% |
| 2014-12-31 | $0.45 B | -9.29% |
| 2013-12-31 | $0.50 B | 10.33% |
| 2012-12-31 | $0.45 B | 5% |
| 2011-12-31 | $0.43 B | 172.16% |
| 2010-12-31 | $0.16 B | 46.79% |
| 2009-12-31 | $0.10 B | 2040.62% |
| 2008-12-31 | $5.09 M | -97.45% |
| 2007-12-31 | $0.20 B | 0% |
| 2006-12-31 | $0.20 B | 0% |
| 2005-12-31 | $0.20 B | 0% |
| 2004-12-31 | $0.20 B | -6.46% |
| 2003-12-31 | $0.21 B | 6.83% |
| 2002-12-31 | $0.20 B | -0.21% |
| 2001-12-31 | $0.20 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 985.20% | 🇺🇸 USA |
 Novartis NVS | $26.34 B | 874.80% | 🇨🇭 Switzerland |
 Amgen AMGN | $64.61 B | 2,290.51% | 🇺🇸 USA |
 Sanofi SNY | $20.36 B | 653.53% | 🇫🇷 France |
 Biogen BIIB | $7.33 B | 171.49% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $1.30 B | -51.70% | 🇺🇸 USA |